Imidazole-series compound

Details Imidazole-series compound Imidazole-series compound

C - Chemistry, Metallurgy

07

D

C07D 401/04 (2006.01) C07D 403/04 (2006.01)

Patent

CA 2154467

The present invention aims at providing a novel compound having histamine H3 receptor antagonism and relates to a compound represented by the following general formula (0) Image (0) wherein m represents an integer of from 4 to 6; R1 represents a hydrogen atom or a lower alkyl or aralkyl group; R2 and R3 may be either the same or different from each other and each represents a hydrogen atom or a lower alkyl group; R4 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, a cycloalkylalkyl group a substituted or unsubstituted aryl group or a substituted or unsubstituted aralkyl group; and Z represents R5 or A-A6, wherein A represents S or 0, R5 represents a hydrogen atom, a lower alkyl group, a substituted or unsubstituted aryl group or a substituted or unsubstituted aralkyl group, and R6 represents a lower alkyl group, a lower alkenyl group, a lower alkynyl group or a substituted or unsubstituted aralkyl group; or pharmaceutically acceptable salts thereof.

Affiliated with

Also associated with

Rating

Imidazole-series compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazole-series compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole-series compound will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2068404